The global DNA methylation market is expected to grow at a CAGR of around 13.2% from 2020 to 2027 and expected to reach the market value of around US$ 2,726.2 Bn by 2027.
DNA methylation is the way of allocating a chemical group to DNA. This group is typically added to key sites on the DNA, where it inhibits the proteins that attach to DNA to "read" the gene. Demethylation is a process that can be used to remove the chemical group. Typically, methylation "turns" genes "off," whereas demethylation "turns" genes "on."
Market Dynamics
Big calls for "DNA methylation" for cancer treatment
Cancer-related DNA hypo-methylation is found throughout the human genome, according to Longdom Publishing. Cancer progresses due to hyper-methylation by suppressing the tumor suppressor gene. Recent research on tissue-specific methylation has suggested that DNA hypo-methylation aids tumor transformation through a variety of pathways. Cancer-related DNA methylation absence may alter transcription. Newer research has revealed that genomic 5-hydroxymethylcytosine is an intermediate in DNA de-methylation that results in cancer-related losses. Furthermore, decreased hydroxyl-methylation and DNA methylation both play important roles in carcinogenesis. Besides that, one of the most prominent epigenetic changes observed in cancer is DNA methylation alteration. Because DNA derived from cancer cells is a stable molecule that is easily detectable in clinical specimens such as blood, sputum, urine, and stool, DNA methylation alteration in tumorigenesis has emerged as one of the promising candidate biomarkers for cancer patients' early detection, prognosis, therapeutic response prediction, and recurrence monitoring. The field of DNA methylation biomarking research is rapidly evolving, with promising results that have the potential to provide enormous benefits to cancer patients in the future.
Technological advancements bolster the growth of global DNA methylation market
According to the technique revealed in the Annals of Oncology paper, one of the mechanisms of gene expression regulation is epigenetic silencing mediated by DNA methylation. The new technology is justified by the fact that the methylation pattern found in a tumor cell differs from that of a healthy cell. The detection of DNA fragments released by tumor cells is made possible by analyzing the methylation pattern in cfDNA. Because there are many methylated regions in the DNA, this provides high sensitivity and specificity because there are many possibilities for detecting those different DNA methylated regions present in cancer. The newer technology detects genomic alterations in the DNA molecules released by tumor cells. The newer technique not only detects and monitors the presence, progression, or response of a tumor to treatment, but it also provides information about the specific mutations that a tumor has.
Market Segmentation
The global DNA methylation market is segmented based on product, application, technology, and end-user. By product, the market is segmented as enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. Enzymes are further sub segmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Further, instruments and consumables are sub segmented as next-generation sequencers, qPCR, mass spectrometers, sonicators, and others. Kits is further sub segmented as bisulfite conversion kits, ChIP-sequencing kits, RNA sequencing kits, whole genomic amplification kits, 5-hmC and 5-mC analysis kits, and others. Reagents are further sub segmented as antibodies, buffers, histones, magnetic beads, primers, and among others. By application, the market is segmented as oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and others. Based on application, the market is segmented as oncology, metabolic diseases, immunology, and others. Based on technology, the market is segregated as DNA methylation, histone modifications, and others. By end-user, the market is segmented as academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs)
In terms of products, reagents are expected to dominate the market during the forecast period. The most common DNA methylation enzymes are DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Antibodies, PCR reagents, histones, primers, electrophoresis reagents, nucleic acid reagents, and buffers are also common epigenetic reagents. “PyroMark Q24” is one of the advanced reagents that use advanced pyrosequencing chemistry to provide even better real-time sequence-based detection and quantification than previously available. In the past, DNA methylation accounted for the largest market share by technology, and this trend is expected to continue throughout the forecast period. Because DNA methylation is the covalent addition of a methyl group to the cytosine ring, it inhibits transcription. Methylation-sensitive PCR refers to sensitive bisulphite modification followed by PCR (MSP). Furthermore, by application, oncology is the largest contributor in the global DNA methylation market, with the largest share expected in the coming years. The rising prevalence of cancer worldwide, combined with an increase in cancer-related deaths, is a major contributor to segmental growth. Furthermore, the introduction of new products and the potential commercialization of products stimulate the growth of the segment, thereby contributing to the growth of the global DNA methylation market. Academic and research institutes are expected to dominate the global DNA methylation market by end-user. The Garvan Institute of Medical Research, for example, focuses on identifying DNA methylation changes associated with disease in order to improve the interpretation of diagnostic samples and guide treatment decisions.
Regional Overview
North America will take the lead in the global DNA methylation market in the coming years, with a sizable market share. The government in this region is encouraging ongoing epigenetic research activities through funding, which supports the growth of the North America regional market. But apart from that, the presence of advanced healthcare facilities and consistent advancements in diagnostic procedures stimulate regional market growth, ultimately contributing to the growth of the global DNA methylation market. One of the major factors driving the growth of the global DNA methylation market is the widespread use of technologically advanced facilities. Asia Pacific, on the other hand, is expected to grow the fastest during the forecast period due to rising disposable income, high unmet medical needs of patient group, rising awareness of early diagnosis, and availability of effective treatment options in emerging countries, particularly China and India, which stimulates the growth of the global DNA methylation market.
Competitive Landscape
The prominent players involvd in global DNA methylation market involve Illumina, Inc., Thermo Fisher Scientific, Merck Millipore, Abcam plc, Active Motif, Bio-Rad Laboratories, Inc., New England Biolabs, Agilent Technologies, Inc., QIAGEN, Zymo Research, PerkinElmer, Inc., Diagenode, and among others
Market Segmentation
Market By Product
Enzymes
- DNA-modifying Enzymes
- Protein-modifying Enzymes
- RNA-modifying Enzymes
Instruments and Consumables
- Next-generation Sequencers
- qPCR
- Mass Spectrometers
- Sonicators
- Others
Kits
- Bisulfite Conversion Kits
- ChIP-sequencing Kits
- RNA sequencing Kits
- Whole Genomic Amplification Kits
- 5-hmC and 5-mC Analysis Kits
- Others
Reagents
- Antibodies
- Buffers
- Histones
- Magnetic Beads
- Primers
- Others
Bioinformatics Tools
Market By Application
Oncology
Metabolic Diseases
Immunology
Others
Market By Technology
DNA Methylation
Histone Modifications
Others
Market By End User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1. Industry Overview of DNA Methylation
1.1. Definition and Scope
1.1.1. Definition of DNA Methylation
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global DNA Methylation Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. DNA Methylation Market By Product
1.2.3. DNA Methylation Market By Application
1.2.4. DNA Methylation Market By Technology
1.2.5. DNA Methylation Market By End User
1.2.6. DNA Methylation Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. DNA Methylation Market By Product
4.1. Introduction
4.2. DNA Methylation Revenue By Product
4.2.1. DNA Methylation Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Enzymes
4.2.2.1. Enzymes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.2. DNA-modifying Enzymes
4.2.2.2.1. DNA-modifying Enzymes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.3. Protein-modifying Enzymes
4.2.2.3.1. Protein-modifying Enzymes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.4. RNA-modifying Enzymes
4.2.2.4.1. RNA-modifying Enzymes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Instruments and Consumables
4.2.3.1.1. Instruments and Consumables Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.2. Next-generation Sequencers
4.2.3.2.1. Next-generation Sequencers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.3. qPCR
4.2.3.3.1. qPCR Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.4. Mass Spectrometers
4.2.3.4.1. Mass Spectrometers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027|
4.2.3.5. Sonicators
4.2.3.5.1. Sonicators Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.6. Others
4.2.3.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Kits
4.2.4.1.1. Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.2. Bisulfite Conversion Kits
4.2.4.2.1. Bisulfite Conversion Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.3. ChIP-sequencing Kits
4.2.4.3.1. ChIP-sequencing Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.4. RNA sequencing Kits
4.2.4.4.1. RNA sequencing Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.5. Whole Genomic Amplification Kits
4.2.4.5.1. Whole Genomic Amplification Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.6. 5-hmC and 5-mC Analysis Kits
4.2.4.6.1. 5-hmC and 5-mC Analysis Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.7. Others
4.2.4.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Reagents
4.2.5.1.1. Reagents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5.2. Antibodies
4.2.5.2.1. Antibodies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5.3. Buffers
4.2.5.3.1. Buffers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5.4. Histones
4.2.5.4.1. Histones Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5.5. Magnetic Beads
4.2.5.5.1. Magnetic Beads Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5.6. Primers
4.2.5.6.1. Primers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5.7. Others
4.2.5.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Bioinformatics Tools
4.2.6.1.1. Bioinformatics Tools Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. DNA Methylation Market Revenue By Application
5.1. Introduction
5.2. DNA Methylation Revenue (US$ Mn) By Application
5.2.1. DNA Methylation Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Oncology
5.2.2.1. Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Metabolic Diseases
5.2.3.1. Metabolic Diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Immunology
5.2.4.1. Immunology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Others
5.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. DNA Methylation Market By Technology
6.1. Introduction
6.2. DNA Methylation Revenue (US$ Mn) By Technology
6.2.1. DNA Methylation Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
6.2.2. DNA Methylation
6.2.2.1. DNA Methylation Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.3. Histone Modifications
6.2.3.1. Histone Modifications Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.4. Others
6.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
CHAPTER 7. DNA Methylation Market By End User
7.1. Introduction
7.2. DNA Methylation Revenue (US$) By End User
7.2.1. DNA Methylation Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
7.3. Academic and Research Institutes
7.3.1. Academic and Research Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Pharmaceutical and Biotechnology Companies
7.4.1. Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.5. Contract Research Organizations (CROs)
7.5.1. Contract Research Organizations (CROs) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America DNA Methylation Market By Country
8.1. North America DNA Methylation Overview
8.2. U.S.
8.2.1. U.S. DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.S. DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.S. DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.2.4. U.S. DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Canada
8.3.1. Canada DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Canada DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Canada DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.3.4. Canada DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe DNA Methylation Market By Country
9.1. Europe DNA Methylation Market Overview
9.2. U.K.
9.2.1. U.K. DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.2. U.K. DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.2.3. U.K. DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.2.4. U.K. DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.3. Germany
9.3.1. Germany DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.2. Germany DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3.3. Germany DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.3.4. Germany DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.4. France
9.4.1. France DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.2. France DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4.3. France DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.4.4. France DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.5. Spain
9.5.1. Spain DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.2. Spain DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5.3. Spain DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.5.4. Spain DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.2. Rest of Europe DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6.3. Rest of Europe DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
9.6.4. Rest of Europe DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific DNA Methylation Market By Country
10.1. Asia Pacific DNA Methylation Market Overview
10.2. China
10.2.1. China DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. China DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3. China DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.2.4. China DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Japan
10.3.1. Japan DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Japan DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3. Japan DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.3.4. Japan DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. India
10.4.1. India DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.2. India DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4.3. India DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.4.4. India DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.5. Australia
10.5.1. Australia DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.5.2. Australia DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5.3. Australia DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.5.4. Australia DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.6. South Korea
10.6.1. South Korea DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.6.2. South Korea DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6.3. South Korea DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.6.4. South Korea DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.7.2. Rest of Asia-Pacific DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7.3. Rest of Asia-Pacific DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.7.4. Rest of Asia-Pacific DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America DNA Methylation Market By Country
11.1. Latin America DNA Methylation Market Overview
11.2. Brazil
11.2.1. Brazil DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Brazil DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3. Brazil DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
11.2.4. Brazil DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. Mexico
11.3.1. Mexico DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. Mexico DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3. Mexico DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
11.3.4. Mexico DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Latin America DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3. Rest of Latin America DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
11.4.4. Rest of Latin America DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa DNA Methylation Market By Country
12.1. Middle East & Africa DNA Methylation Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.2.2. Saudi Arabia DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.2.3. Saudi Arabia DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
12.2.4. Saudi Arabia DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.3. UAE
12.3.1. UAE DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.3.2. UAE DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3.3. UAE DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
12.3.4. UAE DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa DNA Methylation Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.4.2. Rest of Middle East & Africa DNA Methylation Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4.3. Rest of Middle East & Africa DNA Methylation Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
12.4.4. Rest of Middle East & Africa DNA Methylation Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of DNA Methylation
13.1. DNA Methylation Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global DNA Methylation Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Illumina, Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Illumina, Inc. 2019 DNA Methylation Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Thermo Fisher Scientific
14.3. Merck Millipore
14.4. Abcam plc
14.5. Active Motif
14.6. Bio-Rad Laboratories, Inc.
14.7. New England Biolabs
14.8. Agilent Technologies, Inc.
14.9. QIAGEN
14.14. Zymo Research
14.11. PerkinElmer, Inc.
14.12. Diagenode
Others
